Results 91 to 100 of about 129,511,766 (119)

Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2

open access: yes, 2012
SummaryTo initiate adaptive immunity, dendritic cells (DCs) move from parenchymal tissues to lymphoid organs by migrating along stromal scaffolds that display the glycoprotein podoplanin (PDPN). PDPN is expressed by lymphatic endothelial and fibroblastic
Wucherpfennig, Kai W   +25 more
core   +1 more source

The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.

open access: yes, 2009
The inhibitory effect of R406 provides direct evidence of a role for Syk in GPVI, CLEC-2 and integrin alphaIIbbeta3 signaling in human platelets. Further, the results demonstrate a critical role for Syk in mediating tyrosine phosphorylation of CLEC-2 ...
Spalton, J C   +5 more
core   +3 more sources

PB0419 The Molecular Basis of Carrageenan-Induced Thrombosis Involves Platelet Activation via C-Type Lectin Like Receptor 2 (CLEC-2)

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2023
R. Yokomori   +6 more
openaire   +1 more source

The role of the (hem)ITAM-coupled receptors C-type lectin-like receptor 2 (CLEC-2) and Glycoprotein (GP) VI for platelet function: in vitro and in vivo studies in mice [PDF]

open access: yes, 2011
Die Thrombozytenaktivierung und –adhäsion sowie die nachfolgende Thrombusbildung ist ein essentieller Prozess in der primären Hämostase, der aber auch irreversible Gefäßverschlüsse und damit Herzinfarkt oder Schlaganfall verursachen kann. Erst kürzlich wurde beschrieben, dass der C-type lectin-like receptor 2 (CLEC-2) auf der Thrombozytenoberfläche ...
openaire  

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides

open access: yes, 2017
peer reviewedBackground: Synthetic phosphorothioate-modified CpG oligodeoxynucleotides (CpG ODNs) display potent immunostimulatory properties that are widely exploited in clinical trials of anticancer treatment.
Delierneux, Céline   +23 more
core   +1 more source

Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.

open access: yes, 2008
Binding of the snake venom protein rhodocytin to CLEC-2, a receptor on the surface of human platelets, initiates a signaling cascade leading to platelet activation and aggregation. We have previously solved the structure of CLEC-2.
Aleksandra A. Watson   +2 more
core   +1 more source

Development of an automated chemiluminescence enzyme immunoassay for the measurement of soluble C-type lectin-like receptor 2 (sCLEC-2) and molecular forms of sCLEC-2 measured in patient plasma

open access: yesPlatelets
Soluble CLEC-2 is anticipated to have various clinical applications as a novel biomarker for in vivo platelet activation, assessable using plasma obtained through routine sampling procedures. While sCLEC-2 has been measured using ELISA, we have developed
Masahide Kawamura   +8 more
doaj   +1 more source

CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses

open access: yes, 2011
Myeloid cells express a plethora of C-type lectin receptors (CLRs) that can regulate immune responses. CLEC-2 belongs to the Dectin-1 sub-family of CLRs that possess an extracellular C-type lectin-like domain and a single intracellular hemITAM motif ...
Lambrecht, Bart   +21 more
core   +1 more source

Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection

open access: yesNature Communications
Inflammation-induced thrombosis is a common consequence of bacterial infections, such as those caused by Salmonella Typhimurium (STm). The presentation of multi-organ thrombosis post-infection that develops and resolves with organ-specific kinetics ...
Marisol Perez-Toledo   +20 more
doaj   +1 more source

Cellular regulation of the hemITAM-coupled platelet receptor C-type lectin-like receptor 2 (CLEC-2): In vitro and in vivo studies in mice

open access: yes, 2018
Die Aggregation von Thrombozyten ist ein essentielle Prozess, um Blutungen nach einer Gefäßverletzung zu stoppen. Sie kann aber auch zu akuten thrombotischen Erkrankungen, wie Herzinfarkt und Schlafanfall, führen. Die Bildung eines stabilen Thrombus ist ein dynamischer Prozess, der ein definiertes Zusammenspiel von thrombozytären Rezeptoren und ...
openaire   +1 more source

Home - About - Disclaimer - Privacy